| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0043 | 1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |